drugset / Trial / NCT06752525

Opioid Sparing Effect of Sphenopalatine Ganglion Block in Functional Endoscopic Sinus Surgery: a Randomized Controlled Clinical Trial.

NCT06752525

Phase 4 Not yet recruiting 60 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Functional endoscopic sinus surgery (FESS) is widely recognized as a safe and preferred treatment option for various conditions, particularly nasal polyps and rhinosinusitis . This technique has been shown to improve postoperative symptoms by 86.3% in patients with chronic inflammatory paranasal sinus diseases . The aim of this study is to evaluate the effect of adding of MgSO4 to bupivacaine via SPGB block for postoperative pain for 24 hours in patients scheduled for FESS as opioid free anaesthesia.

Timeline

Start
2025-01-01
Primary completion
2026-01-01
Completion
2026-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 500 mg Intranasal
Background Bupivacaine Other / unclassified 1.5 ml Intranasal

Indications